Atherosclerosis in Apolipoprotein E-Deficient Mice is Decreased by the Suppression of Endogenous Sex Hormones

To elucidate the influence of gonadotropins, endogenous sex hormones and testosterone on atherosclerosis, 4-week-old male and female apoE-deficient mice received either 100 µg subcutaneous injections of the gonadotropin-releasing hormone (GnRH) antagonist Cetrorelix every 48 hours or a subcutaneous implantation of a permeable silastic tube with 35 mg of testosterone. Control mice received either subcutaneous injections of saline, a silastic implant with saline, or no treatment. The animals were sacrificed after eight weeks of treatment; blood was obtained by cardiac puncture and the aorta was taken out and prepared. The suppression of testosterone led to an increase in atherosclerosis in both the sinus aortae and the ascending aorta despite increases of cholesterol in male and decreases of HDL cholesterol in female mice. Treatment with testosterone led to small but significant increases of cholesterol levels and atherosclerotic lesions in male mice. Female mice showed no change in lipids and fewer atherosclerotic lesions. In conclusion, the suppression of gonadotropins appears to have a moderate anti-atherogenic effect. The effect of testosterone appears to be either neutral or opposed by gonadotropins.

Atherosclerosis - Animal Model - Testosterone - Gonadotropin-Releasing Hormone Antagonist

References

• 1 Lobo R A. Treatment of the postmenopausal woman: basic and clinical aspects.  New York:; Raven Press, 1994
• 2 Kaufmann J M, Vermeulen A. Androgens in male senescence. In: Nieschlag E, Behre HM (eds). Testosterone: Action, Deficiency, Substitution. 2nd Edition.  Berlin:; Springer Verlag, 1998: 437-472
• 3 Liu P Y, Handelsman D J. Androgen therapy in non-gonadal disease. In: Nieschlag E, Behre HM (eds). Testosterone: Action, Deficiency, Substitution. 2nd Edition.  Berlin:; Springer Verlag, 1998: 473-512
• 4 Nieschlag E, Behre H M. Testosterone in male contraception. In: Nieschlag E, Behre HM (eds). Testosterone: Action, Deficiency, Substitution. 2nd Edition.  Berlin:; Springer Verlag, 1998: 513-528
• 5 Schänzer W. Abuse of androgens and detection of illegal use. In: Nieschlag E, Behre HM (eds). Testosterone: Action, Deficiency, Substitution. 2nd Edition.  Berlin:; Springer Verlag, 1998: 545-566
• 6 von Eckardstein A. Androgens, cardiovascular risk factors, and atherosclerosis. In: Nieschlag E, Behre HM (eds). Testosterone: Action, Deficiency, Substitution. 2nd Edition.  Berlin:; Springer Verlag, 1998: 229-258
• 7 Alexandersen P, Haarbo J, Christiansen C. The relationship of natural androgens to coronary heart disease in males: a review.  Atherosclerosis. 1996;  125 1-13
• 8 Bagatell C J, Bremner W J. Androgens in men - uses and abuses.  N Engl J Med. 1996;  334 107-114
• 9 Rosano G MC, Leonardo F, Pagnotta P, Pelliccia F, Panina G, Cerquetani E, della Monica P L, Bonfigli B, Volpe M, Chierchia S L. Acute anti-ischemic effect of testosterone in men with coronary artery disease.  Circulation. 1999;  99 1666-1670
• 10 Larsen B A, Nordestgaard B, Stender S, Kjeldsen K. Effect of testosterone on atherogenesis in cholesterol-fed rabbits with similar plasma cholesterol levels.  Atherosclerosis. 1993;  99 79-86
• 11 Fogelberg M, Björkhem I, Diczfalusy U, Henriksson P. Stanozolol and experimental atherosclerosis: atherosclerosis development and blood lipids during anabolic steroid therapy of New Zealand white rabbits.  Scand J Clin Lab Invest. 1990;  50 693-700
• 12 Alexandersen P, Haarbo J, Byrjalsen I, Lawetz H, Christiansen C. Natural androgens inhibit male atherosclerosis. A study in castrated, cholesterol-fed rabbits.  Circ Res. 1999;  84 813-819
• 13 Bruck B, Brehme B, Gugel N, Hanke S, Finking G, Lutz C, Benda N, Schmahl F W, Haasis R, Hanke H. Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits.  Arterioscler Thromb Vasc Biol. 1997;  17 2192-2199
• 14 Adams M R, Williams J K, Kaplan J R. Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness.  Arterioscler Thromb Vasc Biol. 1995;  15 562-570
• 15 Toda T, Toda Y, Cho B H, Kummerow F A. Ultrastructural changes in the comb and aorta of chicks fed excess testosterone.  Atherosclerosis. 1984;  51 47-53
• 16 Behre H M, Klein B, Steinmeyer E, McGregor G P, Voigt K, Nieschlag E. Effective suppression of luteinizing hormone and testosterone by single doses of the new gonadotropin-releasing hormone antagonist cetrorelix (SB-75) in normal men.  J Clin Endocrinol Metab. 1992;  75 393-398
• 17 Behre H M, Kliesch S, Pühse G, Reissmann T, Nieschlag E. High loading and low maintenance doses of a gonadotropin-releasing hormone antagonist effectively suppress serum luteinizing hormone, follicle stimulating hormone, and testosterone in normal men.  J Clin Endocrinol Metab. 1997;  82 1403-1408
• 18 Piedrahita J A, Zhang S H, Hagamann J, Oliver P M, Maeda N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells.  Proc Natl Acad Sci USA. 1992;  89 4471-4475
• 19 Zhang S H, Reddick R L, Piedrahita J A, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.  Science. 1992;  258 468-471
• 20 Plump A S, Smith J D, Hayek T, Aalto-Setälä K, Walsh A, Verstuyft J G, Rubin E M, Breslow J L. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.  Cell. 1992;  71 343-353
• 21 Bourassa P AK, Milos M M, Gaynor BJ, Breslow J L, Aiello R J. Estrogen reduces atherosclerotic lesion development in apolipoprotein E deficient mice.  Proc Natl Acad Sci USA. 1996;  93 10 022-10 027
• 22 Elhage R, Arnal J F, Pieraggi M -T, Duverger N, Fiévet C, Faye J C, Bayard F. 17β-estradiol prevents fatty streak formation in apolipoprotein E-deficient mice.  Arterioscler Thromb Vasc Biol. 1997;  17 2679-2684
• 23 Huang Y, Langer C, Raabe M, Wiesenhütter B, Wu S, Seedorf U, Maeda N, Assmann G, von Eckardstein A. Effects of genotype and diet on cholesterol efflux into plasma and lipoproteins of normal, apolipoprotein A-I-, and apolipoprotein E-deficient mice.  Arterioscler Thromb Vasc Biol. 1997;  17 2010-2019
• 24 Paigen B, Morrow A, Holmes P A, Mitchell D, Williams R A. Quantitative assessment of atherosclerotic lesions in mice.  Atherosclerosis. 1987;  68 231-240
• 25 Qiao J -H, Xi P -Z, Fishbein M C, Kreuzer J, Drake T A, Demer L L, Lusis A J. Pathology of atheromous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification.  Arteriosclerosis Thromb. 1994;  14 1480-1497
• 26 Paigen B, Holmes P A, Mitchell D, Albee D. Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57BL/6, BALB/c, and C3H.  Atherosclerosis. 1987;  64 215-221
• 27 Acton S, Rigotti A, Landschulz K T, Xu S, Hobbs H H, Krieger M. Identification of scavenger receptor SR-B1 as a high density lipoprotein receptor.  Science. 1996;  271 518-520
• 28 Kozarsky K F, Donahee M H, Rigotti A, Iqbal S N, Edelman E R, Krieger M. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels.  Nature. 1997;  387 414-416
• 29 Rigotti A, Trigatti B L, Penman M, Rayburn H, Herz J, Krieger M A. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism.  Proc Natl Acad Sci USA. 1997;  94 12 610-12 615
• 30 Ji Y, Jian B, Wang N, Sun Y, Moya M L, Phillips M C, Rothblat G H, Swaney J B, Tall A R. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux.  J Biol Chem. 1997;  272 20 982-20 987
• 31 Li X, Peegel H, Menon K M. In situ hybridization of high density lipoprotein (scavenger, type 1) receptor messenger ribonucleic acid (mRNA) during folliculogenesis and luteinization: evidence for mRNA expression and induction by human chorionic gonadotropin specifically in cell types that use cholesterol for steroidogenesis.  Endocrinology. 1998;  139 3043-3051
• 32 Herman S M, Robinson J TC, McCredie R J, Adams M R, Boyer M J, Celermajer D S. Androgen deprivation is associated with enhanced endothelium-dependent dilatation in adult men.  Arterioscler Thromb Vasc Biol. 1997;  17 2004-2009
• 33 Chou M, Sudhir K, Hutchison S J, Ko E, Amidon T M, Collins P, Chatterjee K. Testosterone induces dilatation of canine coronary conductance and resistance arteries in vivo. .  Circulation. 1996;  94 2614-2619
• 34 Yue P, Chatterjee K, Beale C, Poole-Wilson P A, Collins P. Testosterone relaxes rabbit coronary arteries and aorta.  Circulation. 1995;  91 1154-1160
• 35 Hutchison S J et al. Testosterone worsens endothelial dysfunction associated with hypercholesterolemia and environmental tobacco smoke exposure in male rabbit aorta.  J Am Coll Cardiol. 1997;  29 800-807